The invention relates to CXCR1 and CXCR2 inhibitors for the preparation of a medicament for use as an adjuvant in the transplant of pancreatic islets in Type 1 diabetes patients. In particular, the compounds thagt can be used according to the invention have the following formula (I) in which R and R are as defined in the description.